Intrathecal Onasemnogene abeparvovec for Spinal Muscular Atrophy

Okay, ‍here’s a breakdown of the investigators and key personnel listed in the provided text, organized by institution.I’ve tried to be as comprehensive ‍as possible, noting roles ⁢where specified (Principal Investigator,⁢ Co-investigator, etc.).I’ve also indicated “blinded” status where mentioned.

1. All India Institute of Medical sciences, New Delhi, India

* Principal Investigator: V. ⁤K.Paul
* Sub-investigators: M. Kabra,B. Chakrabarty,G.Kamila, K. Sinha deb
* Study Coordinators:

* (blinded): S. Katoch
* (unblinded): A. Ashik
* Specialist⁤ Consultants:

* Anesthesiologist: P. Khanna
⁣ * Pulmonologist: K. Jat
* ENT Specialist: P. Sagar
⁣ * Cardiologist: S. Kumar Gupta

2. Peking University First hospital/Beijing Children’s Hospital, Capital Medical University/Peking University‍ First Hospital, Beijing, China

* Principal Investigator: H. Xiong
* (Acknowledgement of colleagues in pulmonology,physiotherapy,cardiology,intensive care unit,anesthesiology,and the unblinded team)

3. Yoo Loo Lin School of Medicine, ⁢National University of Singapore, Singapore

* Principal Investigator: S.K.H. Tay
* Co-investigators: F. Wang,V. Han, M. T. C. Lim, R. Taylor, P. Singh, H. Tat ong
*⁤ Site Study ‍Coordinators: R. Lee, V. Asogan, N. Su Htet Wynn

4. Faculty⁣ of Medicine, University of Malaya, Kuala Lumpur, Malaysia ⁢/ M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Selangor, Malaysia

* Principal Investigator: M.-K. Thong
* Co-investigators: C.-Y. fong, W.-K. Lim, L.Li, S.-K. Tae
* Site Study Coordinators: S. Shaharudin, W. muhammad Hazeeq bin Wan Alias
* (Acknowledgement ⁣of many colleagues from ‍various departments and the Clinical Investigations Center, Universiti Malaya Medical Center)

5. Kaohsiung Medical University Hospital, Kaohsiung Medical University/National Yang Ming Chiao Tung University, Kaohsiung, Taiwan

* principal Investigator: Y.-J. Jong
*⁣ Sub-investigators: W.-C. Liang,⁤ J.-H. Hsu, Y.-C. Liu, H.-H. Shih, C.-H.Wang, W.-Y. Hsu, W.-L. Hsiao
* Site Study Coordinator: Y.-H.Chou
* (Acknowledgement of colleagues in pulmonology, physiotherapy, cardiology, neurophysiology, hematology, anesthesiology, and the unblinded team)

6. King Faisal specialist Hospital & Research Centre, Riyadh, Saudi Arabia

* Principal Investigator: M. Al-Muhaizea
* Sub-investigators: M. Abukhaled, E. Tous
* Research Coordinator: N.S.Alrushud

7. St. Jude Children’s Research Hospital, Memphis, TN, USA

* Principal Investigator: R. S. Finkel
* Study approval/site activation: S. H. Hughes, C. C. Quillivan

8. Vietnam National Children’s Hospital, hanoi, Vietnam / Hanoi⁣ University of ⁤Public Health, Hanoi, Vietnam

* Principal Investigators: D.C. Vũ, T.⁤ Minh Dien
* Co-investigators: N. Ngoc Khanh, C. Thi Bich Ngoc,N. Thu Ha, D. thi Thanh Mai, N. Thu Hang, B. Thi Huong
* Pharmacists: P. Thu ‍Ha, D. Thuy Anh
* Site ⁤Study ‍Coordinators: N.Thi Lien,⁢ N. Thi cam,N. hoang Thu
* (Acknowledgement⁣ of colleagues from various departments/centers: Pharmacy Department, Pediatric Cardiology Center, Center for Pediatric Neurology, Department of Imaging Diagnosis, Training and Research Institute for Child Health, and the unblinded and blinded teams)

9. Hospital Tunku Azizah Pediatric Department, Kuala Lumpur, Malaysia

*‍ Principal Investigator: A. Rithauddin Mohamed
* Former ⁤Principal Investigator: P. A/P Anandakrishnan
* Blinded Sub-investigators: D. Binti Abd Hadi, T. Yan Lian, L. Jun Xiong, S. Murugesu
* Blinded Main Study Coordinator: H. Mohd Yassim
* Blinded Study Coordinators: S. Zubaidah Zulkhairi, P. Nur Najwa Binti Nor A

Let